Maximus, Inc. (NYSE:MMS) Shares Purchased by Fuller & Thaler Asset Management Inc.

Fuller & Thaler Asset Management Inc. boosted its stake in Maximus, Inc. (NYSE:MMS - Free Report) by 7.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,234,933 shares of the health services provider's stock after buying an additional 84,835 shares during the quarter. Fuller & Thaler Asset Management Inc. owned approximately 2.16% of Maximus worth $92,188,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. Norges Bank purchased a new position in shares of Maximus in the fourth quarter valued at approximately $71,443,000. Federated Hermes Inc. raised its position in shares of Maximus by 74.8% during the 4th quarter. Federated Hermes Inc. now owns 882,953 shares of the health services provider's stock valued at $65,912,000 after buying an additional 377,705 shares during the period. Marshall Wace LLP lifted its holdings in Maximus by 1,319.1% in the fourth quarter. Marshall Wace LLP now owns 224,267 shares of the health services provider's stock valued at $16,742,000 after acquiring an additional 208,463 shares during the last quarter. Vanguard Group Inc. raised its position in Maximus by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider's stock valued at $488,829,000 after purchasing an additional 205,564 shares during the period. Finally, Dimensional Fund Advisors LP lifted its stake in shares of Maximus by 14.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,406,592 shares of the health services provider's stock valued at $105,001,000 after purchasing an additional 177,075 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Maximus Stock Up 1.9 %

Shares of NYSE MMS opened at $68.19 on Wednesday. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. The business's 50 day moving average is $67.62 and its two-hundred day moving average is $74.96. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $93.97. The firm has a market cap of $3.86 billion, a price-to-earnings ratio of 14.66 and a beta of 0.68.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Research analysts predict that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.76%. The ex-dividend date of this dividend is Thursday, May 15th. Maximus's payout ratio is 25.81%.

Insider Activity at Maximus

In related news, Director Jan Madsen sold 2,439 shares of Maximus stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the transaction, the director now directly owns 18,097 shares in the company, valued at approximately $1,225,347.87. This trade represents a 11.88 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Ilene R. Baylinson sold 14,500 shares of the company's stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the sale, the insider now owns 2,512 shares in the company, valued at approximately $171,167.68. This trade represents a 85.23 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.60% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on MMS shares. StockNews.com downgraded Maximus from a "buy" rating to a "hold" rating in a research report on Friday, February 14th. Raymond James upgraded shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price target for the company in a research report on Thursday, January 2nd.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.